Search

Author/Creator Irvin-Sellers, Oscar

1. 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis. Issue 1 (14th March 2018)

Authors:
van der Heijde, Désirée; Deodhar, Atul; FitzGerald, Oliver; Fleischmann, Roy; Gladman, Dafna; Gottlieb, Alice B; Hoepken, Bengt; Bauer, Lars; Irvin-Sellers, Oscar; Khraishi, Majed; Peterson, Luke; Turkiewicz, Anthony; Wollenhaupt, Jürgen; Mease, Philip J
Journal:
RMD open
Issue:
Volume 4:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study. (March 2021)

Authors:
van der Horst-Bruinsma, Irene E.; van Bentum, Rianne E.; Verbraak, Frank D.; Deodhar, Atul; Rath, Thomas; Hoepken, Bengt; Irvin-Sellers, Oscar; Thomas, Karen; Bauer, Lars; Rudwaleit, Martin
Journal:
Therapeutic advances in musculoskeletal disease
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW. Issue 1 (5th May 2020)

Authors:
van der Horst-Bruinsma, Irene; van Bentum, Rianne; Verbraak, Frank D; Rath, Thomas; Rosenbaum, James T; Misterska-Skora, Maria; Hoepken, Bengt; Irvin-Sellers, Oscar; VanLunen, Brenda; Bauer, Lars; Rudwaleit, Martin
Journal:
RMD open
Issue:
Volume 6:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗